Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
James Shin Initiated (AUTL) at Strong Buy and Held Target at $10 on, Nov 9th, 2023
James Shin of Deutsche Bank, Initiated "Autolus Therapeutics plc" (AUTL) at Strong Buy and Held Target at $10 on, Nov 9th, 2023.
James has made no other calls on AUTL in the last 4 months.
There are 2 other peers that have a rating on AUTL. Out of the 2 peers that are also analyzing AUTL, 0 agree with James's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with James
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Wednesday, October 25th, 2023
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Increased Target to $9 on, Thursday, August 17th, 2023
Contributing Sources